日本队列中多发性骨髓瘤的靶向捕获测序基因组分析
该研究对154例初诊多发性骨髓瘤患者进行靶向捕获测序,发现超二倍体亚型频率较低(37.0%),KRAS突变频率较高(36.4%),IGH-CCND1易位频率较高(26.6%)。携带del(17p)的患者临床结局不良,KRAS突变与携带IGH-CCND1患者的较短生存相关。
要点
- 研究队列中超二倍体亚型占37.0%,KRAS突变占36.4%,IGH-CCND1易位占26.6%。
- 靶向捕获测序可检测罕见的IGH相关染色体易位如IGH-CCND2和IGH-MAFA。
- 10例携带MAX突变的患者均伴有14q23缺失。
核心结论
- 研究提供了多发性骨髓瘤基因组异常的详细图谱,可能具有潜在的临床应用价值。
研究设计与样本
- 采用靶向捕获测序对154例初诊多发性骨髓瘤的日本患者进行分析。
主要发现
- 研究队列中超二倍体亚型频率较低(37.0%),KRAS突变频率较高(36.4%),IGH-CCND1易位频率较高(26.6%)。
- 靶向捕获测序可检测罕见的IGH相关染色体易位如IGH-CCND2和IGH-MAFA。
- 10例携带MAX突变的患者均伴有14q23缺失。
- 携带del(17p)的患者临床结局不良。
- KRAS突变与携带IGH-CCND1的多发性骨髓瘤患者的较短生存相关。
关键数值与推荐
- 超二倍体亚型频率为37.0%。
- KRAS突变频率为36.4%。
- IGH-CCND1易位频率为26.6%。
- MAX突变患者10例,均伴有14q23缺失。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Previous genomic studies have revealed the genomic landscape of myeloma cells. Although some of the genomic abnormalities shown are believed to be correlated to the molecular pathogenesis of multiple myeloma and/or clinical outcome, these correlations are not fully understood. The aim of this study is to elucidate the correlation between genomic abnormalities and clinical characteristics by targeted capture sequencing in the Japanese multiple myeloma cohort. We analysed 154 patients with newly diagnosed multiple myeloma. The analysis revealed that the study cohort consisted of a less frequent hyperdiploid subtype (37·0%) with relatively high frequencies of KRAS mutation (36·4%) and IGH-CCND1 translocation (26·6%) compared with previous reports. Moreover, our targeted capture sequencing strategy was able to detect rare IGH-associated chromosomal translocations, such as IGH-CCND2 and IGH-MAFA. Interestingly, all 10 patients harboured MAX mutations accompanied by 14q23 deletion. The patients with del(17p) exhibited an unfavourable clinical outcome, and the presence of KRAS mutation was associated with shorter survival in patients with multiple myeloma, harbouring IGH-CCND1. Thus, our study provides a detailed landscape of genomic abnormalities, which may have potential clinical application for patients with multiple myeloma.
引用
- Kanamori T, Sanada M, Ri M, et al. Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort. Br J Haematol. 2020. PMID: 32386081. doi:10.1111/bjh.16720
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。